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Abstract: Recently, a population-based case-control study observed a 60% increased odds 
ratio (OR) for cutaneous squamous cell carcinoma (SCC) among women who had ever used 
oral contraceptives (OCs) compared with non users (95% confidence interval (CI) = 1.0–2.5). 
To  further  characterize  the  putative  association  between  OC  use  and  SCC  risk,  we 
conducted a nested case-control study using a large retrospective cohort of 111,521 Kaiser 
Permanente Northern California members.  Multivariable conditional logistic regression was 
used
 to  estimate  ORs  and  CIs  adjusting  for  known  and  hypothesized  SCC  risk  factors.   
Pre-diagnostic OC use was associated with a statistically significant increased OR for SCC 
in univariate analysis (OR = 2.4, CI = 1.2–4.8), with borderline statistical significance in 
multivariable analysis (CI = 2.0, CI = 0.91–4.5).  Given the high incidence of SCC in the 
general population and the prevalent use of OCs among women in the United States, there is 
a need for more large, carefully designed epidemiologic studies to determine whether the 
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observed association between OC use and SCC can be replicated and to better understand 
the etiologic basis of an association if one exists. 
Keywords: squamous cell carcinoma; oral contraceptives; risk factors; epidemiology  
 
1. Introduction  
Cutaneous squamous cell carcinoma (SCC) is the second most common malignancy in the United 
States  [1]  and  its  incidence  is  steadily  rising  [2,3].
  Although  surgical  excision  is  often  curative, 
cutaneous SCCs can metastasize and become fatal, especially in immunocompromised patients [4,5].
 
Treatment  can  cause  significant  disfigurement  and  morbidity  and  accounts  for  high  health-care 
expenditure [6].  Known  risk  factors  associated  with  SCC  can  be  divided  into  host-related  and 
environmental  factors.  Host-related  factors  include  innate  pigmentary  characteristics  [7,8],  sun 
sensitivity [9], precursor lesions [10], genetic predisposition (xeroderma pigmentosa, epidermoplasia 
verruciformis) [11], and immunologic factors [12]. Environmental factors include exposure to physical 
agents, the best characterized of which is ultraviolet light [13-15]. Both UVA and UVB light initiate 
and  promote  carcinogenesis  [16]  and  immunosuppression  [17].  Chronic  cumulative  exposure  to 
ultraviolet  radiation  has  been  established  as  a risk factor for SCC [7,9,18]. Other physical  agents 
include  ionizing  radiation  [18],  chemical  agents  (polycyclic  aromatic  hydrocarbons,  arsenic,  and 
nitrosamines)  [11],  medications  used  for  immunosuppression,  chronic  inflammation  (ulcers,  sinus 
tracts), trauma (burns and scars), and viruses (certain types of human papillomavirus)
 [20,21] also have 
been implicated.  
Epidemiological studies suggest that individuals with cutaneous SCC are more likely to develop 
other  malignancies  compared  with  individuals  who have no history of  non-melanoma skin  cancer 
(NMSC)  [22-24].
    Additionally,  in  patients  who  have  a  history  of  NMSC,  there  is  an  increased 
incidence of and mortality from leukemia, non-Hodgkin's lymphoma, and cancers of the lung, bladder, 
breast,  testis,  salivary  gland,  small  intestine,  and  pharynx  [25].  According  to  several  recent 
epidemiological  studies,  a  history  of  NMSC  may  be  associated  with  20  to  30  percent  increased 
mortality from another type of cancer [23,25]. Understanding exposures that predispose individuals to 
cutaneous SCCs also may shed light on risk factors for these other types of malignancies. Recently, a 
population-based case-control study reported a statistically significant increased risk estimate for SCC 
among  oral  contraceptive  (OC)  users  than  non  users  [26].  Using  an  established  cohort  of  Kaiser 
Permanente  Northern  California  (KPNC)  members  with  data  on  self-reported  pre-diagnostic 
characteristics, we performed a nested case-control study to further examine the putative association 
between OC use and SCC in the context of other environmental and host-related risk factors. 
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2. Methods 
 
2.1. Study Population  
 
The source population consisted of members
 of KPNC who had completed
 at least one Multiphasic 
Health Checkup (MHC) between July 1964
 and August 1973. The MHC, initiated in 1964, was a 
voluntary,
  comprehensive  health  evaluation  that  included  a  detailed  self-administered  MHC 
questionnaire  (MHCQ),  a  standardized  physical  examination,  and  a  group  of  specialty  
examinations [27].
 The MHC has been used for numerous risk
 factor studies [28-30].
 
This study focused on the program’s medical center in Oakland, which provided health care to many 
of the area’s adult subscribers [31] and had computer-stored surgical pathology records starting in 
1974. These pathology records were coded by histology using Systematized Nomenclature of Human 
and Veterinary Medicine (SNOMED) codes [32]. Tumor registry records, mostly complete from 1969, 
allowed us to identify patients with prior histologically confirmed cancers (other than NMSCs) within 
at  least  five years of their initial SCC diagnosis. These patients (~19%) were not included in the 
selection  of  patients  with  SCC  in  order  to  minimize  the  immediate  effects  of  surveillance  bias, 
treatment  effects,  disease-induced  immunosuppression,  and  the  possibility  of  residual  cancer. 
However, patients with more distant self-reported physician diagnosed cancers, ascertained from their 
earliest  MHCQ,  were  included  in  the  selection  of  SCC  cases  and  analyzed  as  a  covariate  in  our 
statistical model.       
We  examined  the  histology  codes  of  the  111,521  MHC  cohort  members  enrolled  in  Oakland 
between 1964 and
 1973 and identified individuals who had a histology code for a cutaneous SCC 
during follow-up from 1974 through 1995. For each case, we randomly selected up to five controls 
who  were  members  at  the  time  of  case  diagnosis  and  who  were  matched
 for  age  at  the  time  of 
examination (± 2 years), gender, residential postal zip code, and year of health
 checkup (± 5 years). 
Excluded  from  the  analysis  (cases  and  controls)  were  157  (4.5%)  non-Caucasians,  12  (0.34%) 
participants  diagnosed  with  genital  SCCs  and  82  (2.4%)  participants  with  missing  values  on  the 
MHCQ for smoking status, occupational exposures, history of cancer, birth control pill use (if female), 
eye color, or aspirin use. A total of 392 (76%) SCC cases had two or more matched controls. The final 
analysis dataset consisted of 516 cases and 1,690 controls. This study was approved by the Institutional 
Review Board of KPNC.  
 
2.2. Risk Factors  
 
Information on possible SCC risk factors was obtained from each subject's earliest MHCQ and from 
information recorded by the MHC staff (eye color). If data were missing from the earliest MHCQ, they 
were obtained from later pre-diagnostic MHCQs, if available. Maximum follow-up was 22 years, with 
a mean of 19.2 years. Host-related factors were defined as those that are inherent to participants. 
Environmental  factors  were  defined  as  those  derived  from  external  exposures  such  as  OC  use, 
smoking, drug exposure and sun-exposure proxies, including leisure time activities and occupational 
exposure. These risk factors are shown in Table 1. To assess education levels, participants were asked Int. J. Environ. Res. Public Health 2009, 7                 
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to check the highest grade completed in school, and these responses were grouped into those who had 
completed education up to high school, and those who had completed some college or trade school. As 
a marker for pigmentation, eye color was divided into four categories: brown, blue/gray, green, and 
other. Participants also were asked about the number of hours they spent each day in the past year in 
leisure time activities, as well as exercise. 
Table 1. Conditional logistic regression models
 comparing cases and controls.* 
Characteristic  SCC 
 n (%) 
Control 
n (%) 
  Univariate 
   OR (95% CI) 
Multivariate٤ 
OR (95% CI) 
Host Factors 
Marital status
۶ 
     Never married 
          Male 
          Female 
     Married 
          Male 
          Female 
    Separated/divorced/widowed 
          Male 
          Female 
  
 
20   (6) 
7     (4) 
 
237 (74) 
118 (61) 
 
16   (5) 
43   (22) 
 
 
33     (3) 
26     (4) 
 
791   (78) 
402   (59) 
 
65     (6) 
142   (21) 
 
 
1.0    Referent 
1.0    Referent 
 
0.62  (0.31-1.3) 
1.1    (0.45-2.8) 
 
0.66  (0.27-1.7) 
1.3    (0.50-3.5) 
 
 
 1.0   Referent 
 1.0   Referent 
 
0.71  (0.33-1.5) 
 1.5   (0.54-4.3) 
 
0.77  (0.29-2.1) 
1.8    (0.61-5.5) 
Education (years of college)
۶  
     High school or  less 
          Male 
          Female  
     Any college 
          Male 
          Female 
  
 
130  (41) 
94    (48) 
 
176  (55) 
92    (47) 
 
 
  459   (45) 
  368   (54) 
 
(47) 
262   (39) 
 
 
1.0   Referent 
1.0   Referent 
 
1.4   (1.02-1.9) 
1.8   (1.2-2.6)  
 
 
 1.0   Referent 
 1.0   Referent 
 
 1.3   (0.95-1.8) 
 1.9   (1.2-2.8) 
Body Mass Index (kg/m
2)
۶ 
     <20 (underweight) 
          Male 
          Female 
     20-25 (healthy) 
          Male 
          Female 
     > 25  (overweight) 
          Male 
          Female 
 
 
5    (2) 
25  (13) 
 
157 (49) 
109 (56) 
 
150 (47) 
58   (30) 
 
 
17     (2) 
60     (9) 
 
348   (34) 
303   (45) 
 
  434   (43) 
  169   (25) 
 
 
0.64   (0.20-2.0)   
0.95   (0.55-1.6) 
 
1.0    Referent 
1.0    Referent 
 
0.78  (0.60-1.02) 
0.94  (0.63-1.4) 
 
 
0.58   (0.16-2.1) 
1.0     (0.55-1.9) 
 
 1.0    Referent 
 1.0    Referent 
 
0.78  (0.59-1.04) 
 1.1   (0.69-1.6) 
Eye color (right) 
      Brown 
          Male 
          Female 
      Green  
          Male 
          Female 
  
 
72   (22) 
39   (20) 
 
6     (2) 
17   (9) 
 
 
307   (30) 
218   (32) 
 
38     (4) 
36     (5) 
 
 
1.0   Referent 
1.0   Referent 
 
0.73 (0.29-1.9) 
2.7   (1.3-5.5) 
 
 
1.0   Referent 
1.0   Referent 
 
0.63 (0.23-1.8) 
2.6   (1.2-5.5) Int. J. Environ. Res. Public Health 2009, 7                 
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      Blue/gray 
          Male 
          Female 
     Other 
          Male 
          Female 
 
184 (57) 
99   (51) 
 
59   (18) 
40   (21) 
 
495   (49) 
322   (47) 
 
  171   (17) 
  103   (15) 
 
1.6   (1.1-2.0) 
1.7   (1.1-2.6) 
 
1.6   (1.1-2.5) 
2.0   (1.2-3.5) 
 
1.6   (1.1-2.2) 
1.9   (1.2-2.9) 
 
1.5   (0.98-2.4) 
2.2   (1.2-3.9) 
Personal history of cancer
~⁯ 
     No 
          Male 
          Female 
     Yes 
          Male 
          Female 
  
 
290 (90) 
167 (86) 
 
31   (10) 
28   (14) 
 
 
975   (96) 
583   (86) 
 
  36     (4) 
  96     (14) 
 
 
1.0  Referent  
1.0  Referent 
       
2.8  (1.6-4.9) 
1.1  (0.69-1.8) 
 
 
 1.0   Referent 
 1.0   Referent 
 
 2.8   (1.5-5.0) 
0.93  (0.55-1.6) 
Environmental Factors 
Smoking status (cigarettes)  
     Never 
          Male 
          Female 
     Former 
          Male 
          Female 
     Current 
          Male 
          Female 
  
 
123 (38) 
105 (54) 
 
105 (33) 
36   (18) 
 
93   (29) 
54   (28) 
 
 
366  (36) 
397  (58) 
 
384  (38) 
104  (15) 
 
  261  (26) 
  178  (26) 
 
 
1.0   Referent 
1.0   Referent 
 
0.90 (0.65-1.2) 
1.6   (0.99-2.6) 
 
1.0   (0.74-1.4) 
1.0   (0.69.1.6) 
 
 
1.0   Referent 
1.0   Referent 
 
0.91 (0.64-1.3) 
1.6   (0.97-2.8) 
 
1.0   (0.71-1.5) 
1.0   (0.64-1.6) 
Ultraviolet radiation
§ 
     No 
          Male 
          Female 
     Yes  
          Male 
          Female 
 
 
312 (97) 
193 (99) 
 
9    (3) 
2    (1) 
 
 
1005 (99) 
675   (99) 
 
6      (1) 
4      (1) 
 
 
1.0    Referent 
1.0    Referent 
 
4.4    (1.5-13) 
3.0    (0.51-18) 
 
 
1.0    Referent 
1.0    Referent 
 
5.0    (1.7-15) 
2.5    (0.34-20) 
Leisure time activities  
(# hours/day)
†۶ 
     0-1 
          Male 
          Female 
     2-4 
          Male 
          Female      
     5-7 
          Male 
          Female 
     >7  
          Male 
          Female   
 
 
 
32   (10) 
19   (10) 
 
207 (64) 
121 (62) 
 
37   (12) 
23   (12) 
 
10  (3) 
2    (1) 
 
 
 
112   (11) 
89     (13) 
 
651   (64) 
425   (63) 
 
76     (8) 
46     (7) 
 
15     (1) 
7       (1) 
 
 
 
1.0   Referent 
1.0   Referent 
 
1.1   (0.71-1.8) 
1.4   (0.82-2.6) 
 
1.6   (0.84-2.9) 
2.7   (1.2-5.8) 
 
3.3   (1.1-9.5) 
1.4   (0.24-7.7) 
 
 
 
1.0   Referent 
1.0   Referent 
 
1.3   (0.76-2.1) 
1.4   (0.76-2.7) 
 
1.8   (0.92-3.6) 
2.7   (1.1-6.4) 
 
3.8   (1.2-12) 
1.1   (0.18-6.7) Int. J. Environ. Res. Public Health 2009, 7                 
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Table 1. Cont. 
Exercise(# hours/day)
۶ 
     0-1 
          Male 
          Female 
     2-4 
          Male 
          Female 
     5-7 
          Male 
          Female 
     >7 
          Male 
          Female 
 
 
176 (55) 
100 (51) 
 
93   (29) 
57   (29) 
 
10   (3) 
7     (4) 
 
6     (2) 
1     (1) 
 
 
504   (50) 
384   (57) 
 
283   (28) 
150   (22) 
 
41     (4) 
22     (3) 
 
23     (2) 
11     (2) 
 
 
1.0   Referent 
1.0   Referent 
 
0.89 (0.65-1.2) 
1.6   (1.1-2.4) 
 
0.66 (0.30-1.4) 
1.5   (0.58-3.8 
 
0.86  (0.32-2.3) 
0.22  (0.03-1.8) 
 
 
1.0   Referent 
1.0   Referent 
 
0.91 (0.65-1.3) 
1.5   (0.95-2.3) 
 
0.67 (0.29-1.5) 
1.3   (0.44-3.7) 
 
0.82  (0.28-2.4) 
0.15  (0.02-1.5) 
Oral contraceptives
¶  ▲ 
     No 
     Yes 
 
172 (88) 
23   (12) 
 
638   (94) 
41     (6) 
 
 1.0   Referent 
 2.4   (1.2-4.8) 
 
1.0   Referent 
2.0   (0.91-4.5) 
Aspirin (# daily pills)
*۸¶  
     <6 
          Male 
          Female  
     >6 
          Male 
          Female 
 
 
316 (98) 
191 (98) 
 
 5    (2) 
 4    (2) 
 
 
994   (98) 
664   (98) 
 
17     (2) 
15     (2) 
 
 
1.0    Referent 
1.0    Referent 
 
1.1    (0.35-3.2) 
0.76  (0.20-2.9) 
 
 
1.0   Referent 
1.0   Referent 
 
1.0    (0.31-3.3) 
0.69  (0.15-3.1) 
Cortisone type medication
¶   
     No 
          Male 
          Female 
     Yes 
          Male 
          Female 
 
 
310 (97) 
185 (95) 
 
11   (3) 
10   (5) 
 
 
965   (95) 
644   (95) 
 
46     (5) 
35     (5) 
 
 
1.0    Referent 
1.0    Referent 
 
0.80  (0.40-1.6) 
1.2    (0.53-2.6) 
 
 
 1.0   Referent 
 1.0   Referent 
 
0.78  (0.36-1.7) 
 1.1   (0.45-2.6) 
Ultraviolet radiation
§ 
     No 
          Male 
          Female 
     Yes  
          Male 
          Female 
 
 
312 (97) 
193 (99) 
 
9    (3) 
2    (1) 
 
 
1005 (99) 
675   (99) 
 
6      (1) 
4      (1) 
 
 
1.0    Referent 
1.0    Referent 
 
4.4    (1.5-13) 
3.0    (0.51-18) 
 
 
1.0    Referent 
1.0    Referent 
 
5.0    (1.7-15) 
2.5    (0.34-19) 
Dusts  (asbestos,  cement,  or 
grain)
§ 
     No 
          Male 
          Female 
     Yes 
          Male 
          Female 
  
 
 
311 (97) 
195 (100) 
 
10   (3) 
0     (0) 
 
 
 
942   (93) 
677   (100) 
 
69     (7) 
2       (0) 
 
 
 
1.0   Referent 
1.0   Referent 
 
0.41 (0.20-0.83) 
           ---
+ 
 
 
 
1.0   Referent 
1.0   Referent 
 
0.40 (0.19-0.87) 
          ---
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*Controls individually matched by gender, postal zip code of residence at time of diagnosis, birth 
year within 2 years, and year of MHCQ within 5 years. 
٤Adjusted for all other variables in table. 
۶Unknown category not shown.  
†Defined as “Hobby, TV, etc.” 
 Defined as “Walking, sports, etc.” 
~Physician diagnosed.  
*Including Aspirin, Empirin, Anacin, or Bufferin. 
۸Approximate usage on daily basis . 
¶  Used in the past year. 
§Often or daily around at place of work. 
▲Women only. 
+Not computed due to zero referent cell. 
 
The MHCQ inquired about occupational exposure by asking, “In the past year, have you worked in 
a place where you were often or daily around:” followed by a list of 11 categories: (1) chemicals, 
cleaning fluids, or solvents, (2) insect or plant sprays, (3) ammonia, chlorine, ozone, or nitrous gases, 
(4)  engine  exhaust  fumes,  (5)  plastic  or  resin  fumes,  (6)  lead  fumes  or  metal  fumes,  (7)  silica, 
sandblasting, grinding, or rock drilling, (8) X-ray or radioactivity, (9) extreme heat, (10) asbestos, 
cement, or grain dusts, or (11) ultraviolet radiation (UV). All 11 categories of occupational exposures 
were examined for possible association with SCC risk.  
Finally, we ascertained self-reported regular use of three classes of medications postulated a priori 
to be associated with SCC: (1) aspirin (“six tablets or more of aspirin including Empirin, Anacin, or 
Bufferin  almost  every  day”)  hypothesized  to  decrease  SCC  risk  [33,34];  (2)  “cortisone  type 
medication,”  hypothesized  to  increase  SCC  risk  due  to  immunosuppression  [35]
  and  (3)  oral 
contraceptives  (birth  control  pills),  hypothesized  to  increase  SCC  risk  due  to  its  association  with 
anogenital SCCs [36]. 
 
2.3. Statistical Analysis 
  
Odds ratios (ORs) were used as the measure of association for binary outcome variables and were 
computed  using  conditional  logistic  regression  [37].  Normal  theory  approximation  using  Wald’s 
method was used to determine the 95% confidence intervals (CI) for the OR estimates (ORs, hereafter 
referred to as risk) [38]. All variables were included in the multivariable model except for occupational 
exposures not associated with SCC risk in the univariate model. Analyses for oral contraceptive use 
were limited to women. Statistical analyses were performed using SAS, version 9.1 (SAS Institute Inc., 
Cary, NC). 
 
3. Results 
 
A total of 516 participants with SCC included 321 men and 195 women. The mean age was 71.4 
years (standard deviation 11.3, range 33–97). The majority (62%) of SCCs were diagnosed on the head Int. J. Environ. Res. Public Health 2009, 7                 
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and neck consistent with previous reports [3,39]. The remaining tumors were located on the upper 
extremities (11%), trunk (9%), lower extremities (9%), and other non-genital skin (10%).  
 
3.1. Host Factors Associated with SCC 
 
Marital Status. Risk for SCC was increased among women who were currently or ever married, but 
CIs spanned unity.        
Education. Women who completed education beyond high school were at increased risk for SCC 
than those less educated. Although positive in direction, the effect was diminished among men.   
Body Mass Index. Risk for SCC was not increased for any category of body mass index. 
Eye Color. Blue/gray eye color was associated with an increased risk for SCC. Participants that 
were classified as having “other” eye color also had a higher risk for SCC. We assumed that the 
“other” category was more likely to represent light color eyes, such as hazel. Also, among women, but 
not men, green eye color was associated with an increased risk for SCC.  
Personal History of Cancer. Men, but not women, who self-reported a history of cancer had an 
increased risk of SCC.  
 
3.2.  Environmental Factors Associated with SCC   
 
Cigarettes. There was no significant association of SCC with cigarette smoking history among men, 
whether comparing never smokers to former or current smokers. A borderline increased risk for SCC 
was observed for women who were former but not current smokers.  
UV  Exposure.  Although  the  MHCQ  did  not  specifically  inquire  about  sun  exposure  habits,  it 
obtained information on occupational UV exposure and time spent in leisure activities or exercise, 
which we reasoned would be the majority of exposure to UV. Men who spent two or more hours a day 
in leisure activities had a higher risk for SCC than those who spent less than two hours, and the risk 
estimate increased with increasing time spent in leisure activities. An increased risk for SCC was 
observed  among  women  who  spent  5–7  hours  a  day  in  leisure  activities  but  the  effect  was  not 
statistically  significant  for  other  levels  of  exposure.  Except  for  a  borderline  significant  effect  for 
women who exercised 2–4 hours a day, this variable was not associated with an increased risk for SCC 
when controlling for other variables in the model. Among men, occupational exposure to UV radiation 
was the strongest predictor of SCC risk in our multivariable model.  
Oral Contraceptive Use. We found a statistically significant risk for SCC in regular users of OC in 
the  univariate  model  (Table  1).  In  the  multivariable  model,  the  OR  changed  little,  although  the 
confidence interval widened yielding an association that was no longer statistically significant. 
Aspirin and Cortisone. Women who consumed >six aspirin tablets a day had a decreased risk for 
SCC but CIs were wide. Cortisone type medications were not associated with SCC risk.  
Other Occupational Exposures. Exposure to dust (asbestos, cement or grains) was associated with 
decreased SCC risk among men. Only two women in our study reported this exposure and neither were 
diagnosed with SCC. The remaining nine occupational exposure categories were not associated with 
future SCC.               Int. J. Environ. Res. Public Health 2009, 7                 
 
 
435 
4.  Discussion 
 
We observed a borderline statistically significant association between oral contraceptive use and 
subsequent SCC risk among women in our cohort. If not merely due to chance or study bias, a possible 
explanation is that oral contraceptives, which contain estrogen (ethinylestradiol) and/or progesterone 
(progestin  or  synthetic  progesterone-like  compounds),  alter  the  serum  estradiol/progesterone  ratio, 
which may influence the oncogenic potential of cutaneous squamous cells [40,41].
 Estrogen receptors 
are present in normal skin [42]. However, SCCs are not believed to express significant amounts of sex 
hormones, suggesting that an association between OC use and SCC may be mediated through non-sex 
hormone pathways [43]. One possible pathway is p53, as estrogen appears to inhibit the actions of this 
tumor suppressor [44]. Inactivation of the p53 gene is believed to play a pivotal gatekeeper role in SCC 
carcinogenesis [45-47]. Risk also may be indirectly increased through interactions with polymorphisms 
in nucleotide excision repair (NER) genes including Xeroderma pigmentosum group D (XPD) [26]. 
Another possibility is that women who use birth control pills may have certain lifestyle factors, such as 
increased sexual activity, which may make them more likely to harbor HPV. Infection with some HPV 
types  has  been  implicated  in  the  pathogenesis  of  cutaneous  SCCs  in  immunocompetent  
hosts [1,21,48-52].
 The association between birth control use, HPV risk and cervical SCC has been 
reported [36,53-55]. A similar association could hold for cutaneous SCC.   
To the best of our knowledge, only one published paper to date has studied the association between 
OC use and SCC [26]. Overall, OC users had a 1.6 adjusted odds ratio (OR) for SCC (CI = 1.0–2.5). 
ORs also were higher among women who last used OCs ≥ 25 years before diagnosis (OR = 2.1,  
CI  =  1.2–3.7),  and  within  group  ORs  increased  with  duration  of  use  (OR  for  ≤  2  years,  1.7;  
CI = 0.9–3.5; OR for 3–6 years, 2.6; CI = 1.0–6.5; OR for ≥7 years, 2.7; CI = 0.9–8.5, Ptrend = 0.01). 
Our results support these previously published findings.             
The  epidemiology  of  SCCs  has  been  difficult  to  characterize  because  conventional  national 
registries, such as the Surveillance, Epidemiology, and End Results (SEER) [56] program exclude 
NMSCs. The unique advantages of the Kaiser Permanente Northern California (KPNC) setting are that 
it closely simulates the surrounding population serving nearly one-third of the insured population of 
Northern California and it houses an electronic database that captures information on all pathology 
specimens received for examination, allowing for thorough and accurate capture of incident SCCs. 
Recall bias was not a concern in our study since OC use was recorded prior to the diagnosis of SCC. 
One potential limitation of this study is residual confounding due to indirect measurement of sun 
exposure, a known risk factor for SCCs [7,9,18]. We used occupational UV and time spent in leisure 
activities, or exercise, as surrogate markers for sun exposure reasoning that sun exposure comes from 
two primary sources: time spent in the sun for leisure/exercise and time spent in the sun related to 
one’s occupation. Among men and to lesser degree women, the strength of association with leisure 
time activities increased with time, supporting the assumption that time spent in leisure activities is 
correlated  with  UV  exposure.  However,  leisure  time  activity  may  have  been  an  inexact  surrogate 
measure of sun exposure as the prompting examples (“Hobby, TV, etc.”) given for the question on the 
MHCQ were vague and may have been interpreted as activities that did not involve sun exposure. Nor 
did the question differentiate between sun and non sun related leisure time activities. Similarly, the Int. J. Environ. Res. Public Health 2009, 7                 
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MHCQ did not specify the type or duration of exercise, or whether the exercise was performed indoors 
versus outdoors. Surprisingly, time spent in exercise was slightly protective among men. Although this 
may seem counterintuitive, it is conceivable that exercise conveys health benefits that may offset the 
negative effect of UV exposure. Furthermore, some participants may have underreported occupational 
sun exposure since they might not have known that "ultraviolet radiation" was a surrogate term for 
"sun  exposure."  While our surrogate measures  of sun  exposure were inexact,  there is no inherent 
reason to believe that sun exposure is associated with OC use and thus unlikely to have affected the 
risk estimates for this variable.               
Attenuation  of  risk  estimates  may  have  occurred  if  some  control  subjects  had  SCC  diagnosed 
outside of the KPNC system. This is unlikely because KPNC is a comprehensive healthcare system and 
members would have to pay out-of-pocket for services received outside the health plan. Also, the 
exposures that we studied were obtained at a single point in time and were not measured over the entire 
study follow-up period.                                   
The possibility remains that women who take oral contraceptive medicines may be more likely to 
interact with the healthcare system and increased risk for SCC may be due to detection bias. However, 
most SCC is diagnosed years after discontinuing OC use. Women with a history of OC use may have 
differentially received greater screening for cervical cancer. In our analysis, we adjusted for level of 
education, a factor believed to influence screening behavior.      
In the current study, OC use was crudely measured as “ever/never” exposed and did not include 
information on dose, duration of OC use, pill composition, or serum estradiol and progesterone levels. 
The potency and overall dose of OCs have changed over time. Our results reflect the use of earlier 
compositions  of  OCs  when hormone doses were considerably higher  and may no longer hold  for 
present day OCs. Nonetheless, this study is an important addition to the literature as the use of OCs 
was recorded prior to skin cancer diagnosis.                         
Although KPNC is generally reflective of the broader population in Northern California [57,58], 
there  are  some  differences  that  may  have  introduced  uncontrolled  factors  regarding  ethnicity  or 
behavior. In addition, individuals who self-selected for the MHCQ may have differed from the larger 
KPNC  population  on  these  as  well  as  other  distinguishing  characteristics  that  were  not  directly 
measured and could have introduced selection and/or detection bias. However, these factors probably 
did not affect the overall validity of our case versus control comparisons.     
Occupational  exposure  to  dust  from  asbestos,  cement,  or  grain  was  included  as  a  potential 
confounding factor in our model based on our hypothesis that occupational dust may coat the skin to 
form a physical barrier to UV light. Previous reports of occupational risk and keratinocyte tumors have 
not  noted  this  specific  association  [59].  Exposure  to  agricultural  dusts  have  been  associated  with 
decreased lung cancer risk [60] suggesting a possible anticancer effect independent of an interaction 
with UV light. However, a healthy worker survival effect and reduced smoking among farmers may 
have been a more plausible explanation for the reduced risk observed among men in our study [61]. A 
limitation of our analysis was that the MHCQ grouped all three types of dust into one category and the 
association of each with SCC might differ.                            
The MHCQ also did not differentiate between types of cancer in the self-reported personal history 
of cancer question. Thus, it was not possible to determine if prior history of self-reported cancer and Int. J. Environ. Res. Public Health 2009, 7                 
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SCC risk was due to a personal history of NMSC versus other cancers. NMSC is the most common 
cancer  in  the  United  States  [4]  and  history  of  NMSC  is  a  major  risk  factor  for  a  new  primary  
SCCs [62]. In our study, risk was higher only among men who self-reported a history of cancer and 
may  reflect  a  higher  incidence  of  NMSC  among  this  group  [63,64].  Although  our  main  effects 
multivariable analysis was adjusted for self-reported personal history of cancer, it is possible that the 
resulting estimate for OC use was affected by residual confounding.            
We did not detect a consistent association between smoking and SCC risk as has been reported by 
some studies [65-68]. Our finding may reflect a different study population which may be susceptible to 
different gene-environment interactions. Or it may be due to our simple smoking history classification 
(i.e., never, former, current) which did not account for pack years smoked, filtered versus unfiltered, 
and  other  detailed  smoking  information.  However,  the  possibility  remains  that  smoking  does  not 
increase SCC risk as was observed in a large occupational cohort study [69].
 Given the uncertainty of 
our smoking variable, we cannot rule out residual confounding in our observed association between 
OC use and SCC.        
The  association  of  SCC  with  innate  pigmentary  factors,  such  as  light  eye  color,  is  well  
established [7,8]
 and is supported by our data. Our results indicate that environmental exposures which 
were used as surrogate markers for UV exposure (occupational UV in the past year and time spent in 
leisure activities) also were highly correlated with SCC risk, as expected. Similarly, our finding of an 
association between higher education and SCC risk has been previously reported [19,70,71]. Education 
level may affect SCC risk through socioeconomic status leading to differences in lifestyle and health-
seeking  behavior.  Those  individuals  with  more  education  may  have  higher  socioeconomic  status, 
allowing them to take mid-winter vacations in sunny locations, leading to higher SCC risk due to more 
frequent episodic sunburns. Alternatively, higher education also may lead to detection bias if more 
educated individuals are more likely to seek health care. Further studies on the mechanisms underlying 
the association between education and SCC risk are needed. 
In summary, we observed a borderline statistically significant increased SCC risk with use of oral 
contraceptives similar to that reported in a recent case-control study. On the present evidence, it is not 
possible to definitively answer the question of how OC use influences SCC risk, if such an association 
exists, or to favor any specific hypothesis. If confirmed in future studies, these results will lead to new 
insight in the etiology of SCCs. 
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